{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:21:35Z","timestamp":1784712095369,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.eprac.2020.11.001","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T13:41:25Z","timestamp":1609422085000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cardiovascular Health Maintenance in Aging Individuals: The\u00a0Implications for Transgender Men and Women on Hormone\u00a0Therapy"],"prefix":"10.1016","volume":"27","author":[{"given":"Daniel J.","family":"Slack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Safer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.eprac.2020.11.001_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.amjcard.2005.10.009","article-title":"Cardiovascular issues in hypogonadism and testosterone therapy","volume":"96","author":"Shabsigh","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.eprac.2020.11.001_bib3","first-page":"CD004143","article-title":"Long-term hormone therapy for perimenopausal and postmenopausal women","author":"Marjoribanks","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.eprac.2020.11.001_bib4","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.118.038584","article-title":"Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy","volume":"139","author":"Nota","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.eprac.2020.11.001_bib5","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1210\/jc.2018-02138","article-title":"Cardiometabolic effects of testosterone in transmen and estrogen plus cyproterone acetate in transwomen","volume":"104","author":"van Velzen","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2020.11.001_bib6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4158\/EP-2017-0247","article-title":"Exogenous testosterone does not induce or exacerbate the metabolic features associated with PCOS among transgender men","volume":"24","author":"Chan","year":"2018","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.eprac.2020.11.001_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.eprac.2020.11.001_bib8","first-page":"210","article-title":"Effect of cross-sex hormone treatment on cardiovascular risk factors in transsexual individuals. Experience in a specialized unit in Catalonia","volume":"62","author":"Quir\u00f3s","year":"2015","journal-title":"Endocrinol Nutr Organo Soc Espanola Endocrinol Nutr"},{"issue":"4","key":"10.1016\/j.eprac.2020.11.001_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.005597","article-title":"Cardiovascular disease risk factors and myocardial infarction in the transgender population","volume":"12","author":"Alzahrani","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"10.1016\/j.eprac.2020.11.001_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-13-0493","article-title":"Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study","volume":"169","author":"Wierckx","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.eprac.2020.11.001_bib11","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1210\/jc.2012-2030","article-title":"Predictive markers for mammoplasty and a comparison of side effect profiles in transwomen taking various hormonal regimens","volume":"97","author":"Seal","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2020.11.001_bib12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A\u00a0long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2020.11.001_bib13","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.fertnstert.2010.03.048","article-title":"The impact of testosterone administration to female-to-male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome","volume":"94","author":"Cupisti","year":"2010","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.eprac.2020.11.001_bib14","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.fertnstert.2008.12.017","article-title":"Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy","volume":"93","author":"Ott","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.eprac.2020.11.001_bib15","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC201907020","article-title":"Care of the transgender patient","volume":"171","author":"Safer","year":"2019","journal-title":"Ann Intern Med"},{"issue":"25","key":"10.1016\/j.eprac.2020.11.001_bib16","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1056\/NEJMcp1903650","article-title":"Care of transgender persons","volume":"381","author":"Safer","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.eprac.2020.11.001_bib17","first-page":"1273","article-title":"Screening for lipid disorders in adults: recommendation statement","volume":"80","year":"2009","journal-title":"Am Fam Physician"},{"issue":"19","key":"10.1016\/j.eprac.2020.11.001_bib18","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2016.15450","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement","volume":"316","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.eprac.2020.11.001_bib19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/01.ATV.20.4.1101","article-title":"Mechanisms regulating LDL metabolism in subjects on peroral and transdermal estrogen replacement therapy","volume":"20","author":"Karjalainen","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.eprac.2020.11.001_bib20","series-title":"High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease","first-page":"139","article-title":"Effects of estrogen on HDL metabolism","author":"Lamon-Fava","year":"2010"},{"issue":"4","key":"10.1016\/j.eprac.2020.11.001_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1172\/JCI108677","article-title":"Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase","volume":"59","author":"Applebaum","year":"1977","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.eprac.2020.11.001_bib22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0022-2275(20)37977-3","article-title":"Concurrent inductions of avian hepatic lipogenesis, plasma lipids, and plasma apolipoprotein B by estrogen","volume":"24","author":"Dashti","year":"1983","journal-title":"J\u00a0Lipid Res"},{"issue":"1","key":"10.1016\/j.eprac.2020.11.001_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jacl.2007.11.001","article-title":"Hypertriglyceridemia-induced pancreatitis created by oral estrogen and in\u00a0vitro fertilization ovulation induction","volume":"2","author":"Lee","year":"2008","journal-title":"J\u00a0Clin Lipidol"},{"issue":"3","key":"10.1016\/j.eprac.2020.11.001_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/MOL.0b013e3283613a94","article-title":"Cholesterol and atherosclerosis: modulation by oestrogen","volume":"24","author":"Barton","year":"2013","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"10.1016\/j.eprac.2020.11.001_bib25","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1016\/S0002-9343(99)80058-8","article-title":"Endogenous sex hormones: impact on lipids, lipoproteins, and insulin","volume":"98","author":"Haffner","year":"1995","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.eprac.2020.11.001_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1530\/eje.0.1510415","article-title":"Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male","volume":"151","author":"Schleich","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.eprac.2020.11.001_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107516","article-title":"Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies","volume":"9","author":"Zhao","year":"2014","journal-title":"PLOS ONE"},{"issue":"11","key":"10.1016\/j.eprac.2020.11.001_bib28","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1210\/jc.2013-1970","article-title":"Beneficial and adverse effects of testosterone on the cardiovascular system in men","volume":"98","author":"Ruige","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2020.11.001_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0025-6196(11)60964-6","article-title":"Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"82","author":"Haddad","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.eprac.2020.11.001_bib30","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1210\/jc.2009-2575","article-title":"Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis","volume":"95","author":"Fern\u00e1ndez-Balsells","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.eprac.2020.11.001_bib31","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1210\/jc.2017-01643","article-title":"Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis","volume":"102","author":"Maraka","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2020.11.001_bib32","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/andr.12382","article-title":"Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review","volume":"5","author":"Velho","year":"2017","journal-title":"Andrology"},{"issue":"11","key":"10.1016\/j.eprac.2020.11.001_bib33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/M15-2345","article-title":"Screening for abnormal blood glucose and type 2 diabetes mellitus: US Preventative Services Task Force recommendation statement","volume":"163","author":"Siu","year":"2015","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.eprac.2020.11.001_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2012-1055","article-title":"The role of estrogens in control of energy balance and glucose homeostasis","volume":"34","author":"Mauvais-Jarvis","year":"2013","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.eprac.2020.11.001_bib35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrendo.2011.242","article-title":"Importance of oestrogen receptors to preserve functional \u03b2-cell mass in diabetes","volume":"8","author":"Tiano","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"10.1016\/j.eprac.2020.11.001_bib36","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jama.2015.10029","article-title":"Prevalence of and trends in diabetes among adults in the United States, 1988-2012","volume":"314","author":"Menke","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.eprac.2020.11.001_bib37","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.2337\/dc12-1020","article-title":"Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study","volume":"36","author":"Brand","year":"2013","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.eprac.2020.11.001_bib38","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/gme.0b013e31820f62d0","article-title":"Menopause and risk of diabetes in the Diabetes Prevention Program","volume":"18","author":"Kim","year":"2011","journal-title":"Menopause N Y N"},{"issue":"10","key":"10.1016\/j.eprac.2020.11.001_bib39","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s00125-017-4346-8","article-title":"Age at natural menopause and risk of type 2 diabetes: a prospective cohort study","volume":"60","author":"Muka","year":"2017","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.eprac.2020.11.001_bib40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.kjms.2014.03.002","article-title":"Combined estrogen replacement therapy on\u00a0metabolic control in postmenopausal women with diabetes mellitus","volume":"30","author":"Xu","year":"2014","journal-title":"Kaohsiung J Med Sci"},{"issue":"5","key":"10.1016\/j.eprac.2020.11.001_bib41","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1463-1326.2005.00545.x","article-title":"Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women","volume":"8","author":"Salpeter","year":"2006","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.eprac.2020.11.001_bib42","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/oby.21033","article-title":"The role of androgens in metabolism, obesity, and diabetes in males and females","volume":"23","author":"Navarro","year":"2015","journal-title":"Obes Silver Spring Md"},{"issue":"4","key":"10.1016\/j.eprac.2020.11.001_bib43","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/diacare.23.4.490","article-title":"Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in\u00a0middle-aged men: prospective results from the Massachusetts male aging\u00a0study","volume":"23","author":"Stellato","year":"2000","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2020.11.001_bib44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1530\/EC-17-0253","article-title":"Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis","volume":"7","author":"Yao","year":"2017","journal-title":"Endocr Connect"},{"issue":"3","key":"10.1016\/j.eprac.2020.11.001_bib45","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1530\/JOE-18-0573","article-title":"Emerging role of testosterone in pancreatic \u03b2 cell function and insulin secretion","volume":"240","author":"Xu","year":"2019","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.001_bib46","article-title":"Association of androgen excess with glucose intolerance in women with polycystic ovary syndrome","author":"Zhang","year":"2018","journal-title":"Biomed Res Int"},{"issue":"8","key":"10.1016\/j.eprac.2020.11.001_bib47","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.2337\/dc13-2845","article-title":"Effect of testosterone treatment on glucose metabolism in men With type 2 diabetes: a randomized controlled trial","volume":"37","author":"Gianatti","year":"2014","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eprac.2020.11.001_bib48","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/13685538.2018.1468429","article-title":"The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes","volume":"21","author":"Groti","year":"2018","journal-title":"Aging Male"},{"issue":"1","key":"10.1016\/j.eprac.2020.11.001_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/jc.2007-1809","article-title":"Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience","volume":"93","author":"Gooren","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"20","key":"10.1016\/j.eprac.2020.11.001_bib50","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/archinte.164.20.2260","article-title":"Venous thromboembolism according to age: the impact of an aging population","volume":"164","author":"Stein","year":"2004","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.eprac.2020.11.001_bib51","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1160\/TH08-04-0255","article-title":"Venous thromboembolism in the elderly: a community-based perspective","volume":"100","author":"Spencer","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.eprac.2020.11.001_bib52","author":"Thacker"},{"issue":"8935","key":"10.1016\/j.eprac.2020.11.001_bib53","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"10.1016\/j.eprac.2020.11.001_bib55","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0002-9378(97)70289-8","article-title":"Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation","volume":"177","author":"Vandenbroucke","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eprac.2020.11.001_bib56","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.thromres.2016.11.015","article-title":"Venous thromboembolism incidence, recurrence, and mortality based on Women\u2019s Health Initiative data and Medicare claims","volume":"150","author":"Burwen","year":"2017","journal-title":"Thromb Res"},{"issue":"17","key":"10.1016\/j.eprac.2020.11.001_bib57","first-page":"U892","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"112","author":"Canonico","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.eprac.2020.11.001_bib58","first-page":"209","article-title":"Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy","volume":"10","author":"Goldstein","year":"2019","journal-title":"J\u00a0Blood Med"},{"key":"10.1016\/j.eprac.2020.11.001_bib60","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.thromres.2018.10.023","article-title":"Testosterone therapy and venous thromboembolism: a systematic review and meta-analysis","volume":"172","author":"Houghton","year":"2018","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.eprac.2020.11.001_bib61","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamainternmed.2019.5135","article-title":"Association of testosterone therapy with risk of venous thromboembolism among men with and without hypogonadism","volume":"180","author":"Walker","year":"2020","journal-title":"JAMA Intern Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20483156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20483156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:07:19Z","timestamp":1761516439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20483156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1530891X20483156"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2020.11.001","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Health Maintenance in Aging Individuals: The\u00a0Implications for Transgender Men and Women on Hormone\u00a0Therapy","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2020.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}